REGENXBIO INC's ticker is RGNX and the CUSIP is 75901B107. A total of 156 filers reported holding REGENXBIO INC in Q3 2023. The put-call ratio across all filers is 0.47 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $275 | -17.2% | 16,727 | +0.8% | 0.00% | – |
| Q2 2023 | $332 | -27.2% | 16,599 | -31.2% | 0.00% | -100.0% |
| Q1 2023 | $456 | -29.3% | 24,135 | -15.1% | 0.00% | 0.0% |
| Q4 2022 | $645 | -99.9% | 28,442 | -0.1% | 0.00% | 0.0% |
| Q3 2022 | $752,000 | +7.1% | 28,457 | +0.2% | 0.00% | 0.0% |
| Q2 2022 | $702,000 | -25.6% | 28,406 | -0.2% | 0.00% | 0.0% |
| Q1 2022 | $944,000 | +1.4% | 28,452 | -0.0% | 0.00% | 0.0% |
| Q4 2021 | $931,000 | -22.2% | 28,466 | -0.2% | 0.00% | 0.0% |
| Q3 2021 | $1,196,000 | -14.1% | 28,526 | -20.4% | 0.00% | 0.0% |
| Q2 2021 | $1,392,000 | +34.2% | 35,818 | +17.8% | 0.00% | 0.0% |
| Q1 2021 | $1,037,000 | -24.8% | 30,400 | 0.0% | 0.00% | -50.0% |
| Q4 2020 | $1,379,000 | +53.2% | 30,400 | -7.0% | 0.00% | +100.0% |
| Q3 2020 | $900,000 | -25.2% | 32,700 | 0.0% | 0.00% | -50.0% |
| Q2 2020 | $1,204,000 | +24.0% | 32,700 | +9.0% | 0.00% | +100.0% |
| Q1 2020 | $971,000 | -21.0% | 30,000 | 0.0% | 0.00% | 0.0% |
| Q4 2019 | $1,229,000 | -0.2% | 30,000 | -13.3% | 0.00% | -50.0% |
| Q3 2019 | $1,232,000 | -30.7% | 34,600 | 0.0% | 0.00% | 0.0% |
| Q2 2019 | $1,777,000 | -22.8% | 34,600 | -13.8% | 0.00% | -33.3% |
| Q1 2019 | $2,301,000 | +52.5% | 40,142 | +11.6% | 0.00% | +50.0% |
| Q4 2018 | $1,509,000 | -48.7% | 35,971 | -7.7% | 0.00% | -33.3% |
| Q3 2018 | $2,943,000 | +29.0% | 38,985 | +22.6% | 0.00% | 0.0% |
| Q2 2018 | $2,282,000 | +155.5% | 31,800 | +6.4% | 0.00% | +200.0% |
| Q1 2018 | $893,000 | -10.2% | 29,900 | 0.0% | 0.00% | 0.0% |
| Q4 2017 | $994,000 | +0.9% | 29,900 | 0.0% | 0.00% | 0.0% |
| Q3 2017 | $985,000 | +66.7% | 29,900 | 0.0% | 0.00% | 0.0% |
| Q2 2017 | $591,000 | +46.7% | 29,900 | +43.1% | 0.00% | 0.0% |
| Q1 2017 | $403,000 | -21.6% | 20,901 | -24.5% | 0.00% | 0.0% |
| Q4 2016 | $514,000 | +75.4% | 27,695 | +32.5% | 0.00% | – |
| Q3 2016 | $293,000 | +75.4% | 20,900 | 0.0% | 0.00% | – |
| Q2 2016 | $167,000 | +128.8% | 20,900 | +207.4% | 0.00% | – |
| Q1 2016 | $73,000 | – | 6,800 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Aquilo Capital Management, LLC | 847,424 | $13,948,599 | 12.64% |
| Sonic GP LLC | 518,079 | $8,527,580 | 8.28% |
| MPM BioImpact LLC | 656,718 | $10,809,578 | 2.89% |
| Redmile Group, LLC | 2,574,042 | $42,368,731 | 2.02% |
| ArchPoint Investors | 224,278 | $3,691,616 | 1.41% |
| WS MANAGEMENT LLLP | 618,131 | $10,174,436 | 0.82% |
| Redwood Wealth Management Group, LLC | 14,360 | $236,366 | 0.28% |
| HARBOR CAPITAL ADVISORS, INC. | 48,559 | $799,281 | 0.17% |
| PRENTISS SMITH & CO INC | 11,240 | $185,010 | 0.14% |
| LIBERTY ONE INVESTMENT MANAGEMENT, LLC | 36,522 | $601,152 | 0.09% |